跳至主要内容
临床试验/DRKS00020525
DRKS00020525已完成不适用

Occurrence of venous thromboembolism after thoracic surgery in patients receiving thrombosis prophylaxis with 40mg enoxaparin.Study 1: Occurrence of venous thrombus embolism after anatomical lung resection in patients with lung cancer - VETEAS-1. Veneous Thrombembolies After (Thoracic) Surgery

ungenklinik,Kliniken der Stadt Köln gGmbH, Uniklinik der Privaten Universität Witten/Herdecke0 个研究点目标入组 108 人开始时间: 2020年1月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
40 Years 至 one(—)
性别
All

入选标准

  • Age = 40 years
  • - Indication for anatomical lung resection
  • - Detected or suspected lung carcinoma
  • - Information and signed consent
  • - The use of antiplatelet drugs (e.g. ASS, Clopidogrel) is permitted

排除标准

  • - VTE in medical history within the last 12 months
  • - severe coagulation disorder (PTT > 40s, Quick < 60%, INR > 1.5, thrombocytes < 50000/µl)
  • - Renal insufficiency (creatinine > 1.15 mg/dl for men and 0.95 mg/dl for women)
  • - Known coagulopathy
  • - Existing drug anticoagulation
  • - Contrast agent allergy
  • - Hyperthyroidism
  • - Pregnancy and lactation

研究者

发起方
ungenklinik,Kliniken der Stadt Köln gGmbH, Uniklinik der Privaten Universität Witten/Herdecke

相似试验